Cargando…
Arginine Is a Novel Drug Target for Arginine Decarboxylase in Human Colorectal Cancer Cells
Colorectal cancer (CRC) has been proven to be highly reliant on arginine availability. Limiting arginine-rich foods or treating patients with arginine-depleting enzymes arginine deiminase (ADI) or arginase can suppress colon cancer. However, arginase and ADI are not the best drug candidates for CRC....
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531272/ https://www.ncbi.nlm.nih.gov/pubmed/37762044 http://dx.doi.org/10.3390/ijms241813741 |